CD274 and neoplasm: Recent studies have tended to focus on specific biomarkers, including PD-L1 expression, HPV status, tumor immune infiltration, immune-associated signatures, gene expression profiles (GEPs), tumor mutational burden (TMB), the status of DNA mismatch repair, and smoking-related signatures.